Press "Enter" to skip to content

New patent expiration for Sumitomo Pharma drug KYNMOBI

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for KYNMOBI
Annual Drug Patent Expirations for KYNMOBI

Kynmobi is a drug marketed by Sumitomo Pharma Am and is included in one NDA. There are fourteen patents protecting this drug.

Drug patent litigation for KYNMOBI.

This drug has two hundred and forty patent family members in twenty-six countries.

The generic ingredient in KYNMOBI is apomorphine hydrochloride. Additional details are available on the apomorphine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions